Stay updated on Cabozantinib for Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s footer revision/version number was updated to v3.5.3 from v3.5.2.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded: Revision: v3.5.2; Deleted: Revision: v3.5.0.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedDeployment of revision v3.5.0 replacing v3.4.3. No visible user-facing content changes were observed.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision note is added: Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0. This appears to be a minor site maintenance update with no changes to study content or user interactions.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.